Literature DB >> 34816362

Obesity phenotypes are, in part, associated with physical activity in diabetic hemodialysis patients.

Beatriz de Oliveira Matos1, Clara Suemi da Costa Rosa2,3, Heitor Siqueira Ribeiro4,5, Natasha Maggi Marcos1, Milene Peron Rodrigues Losilla1, Henrique Luiz Monteiro6, Camila Gimenes1.   

Abstract

PURPOSE: To investigate the prevalence of obesity phenotypes and their association with physical activity levels among diabetic hemodialysis patients.
METHODS: This is a cross-sectional study with 84 diabetic hemodialysis patients (63.5 ± 9.4 years, 54.8% of men). Obesity was diagnosed as high body fat (≥ 40% for male and ≥ 30% for female). Sarcopenic obesity was considered if low skeletal muscle mass (< 20.0 kg for males and < 15.0 kg for females) and obesity were combined. Dynapenic obesity was defined in the presence of low handgrip strength (< 27 kg for males and < 16 kg for females) and obesity. Muscle failure obesity was confirmed in the concomitant presence of obesity, sarcopenia, and dynapenia. Physical activity level was assessed by the Baecke questionnaire and patients were classified as low physical activity according to the first tertile for each of and total domains.
RESULTS: Fifty-four patients (64%) presented obesity. From these, 5 (6%), 19 (23%) and 8 (10%) were classified as sarcopenic obese, dynapenic obese, and muscle failure obese, respectively, and 22 (26%) were only obese. Patients with sarcopenic obesity and muscle failure obesity had lower leisure and locomotion physical activity scores than non-obese, whereas the total domain score did not differ across the groups. Muscle failure obesity was independently associated with low leisure physical activity (OR 10.8, 95% CI 1.3-88.1). Only sarcopenic obesity was independently associated with the locomotion and total physical activity domains (OR 15.4, 95% CI 1.4-90.2 and OR 17.0, 95% CI 1.5-95.4, respectively).
CONCLUSION: Our study found a lower prevalence of sarcopenic obesity compared to dynapenic obesity and muscle failure obesity among diabetic hemodialysis patients. Moreover, sarcopenic obesity and muscle failure obesity, but not dynapenic obesity, were associated with low physical activity levels.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Chronic kidney disease; Dynapenia; Obesity; Physical activity; Sarcopenia

Mesh:

Year:  2021        PMID: 34816362     DOI: 10.1007/s11255-021-03060-w

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  33 in total

Review 1.  Physical inactivity: a risk factor and target for intervention in renal care.

Authors:  Dorien M Zelle; Gerald Klaassen; Edwin van Adrichem; Stephan J L Bakker; Eva Corpeleijn; Gerjan Navis
Journal:  Nat Rev Nephrol       Date:  2017-01-31       Impact factor: 28.314

2.  Sarcopenic Obesity Definitions by Body Composition and Mortality in the Hemodialysis Patients.

Authors:  Rakesh Malhotra; Serpil M Deger; Huzaifah Salat; Aihua Bian; Thomas G Stewart; Cindy Booker; Andrew Vincz; Brianna Pouliot; T Alp Ikizler
Journal:  J Ren Nutr       Date:  2016-11-19       Impact factor: 3.655

Review 3.  Obesity, kidney dysfunction and hypertension: mechanistic links.

Authors:  John E Hall; Jussara M do Carmo; Alexandre A da Silva; Zhen Wang; Michael E Hall
Journal:  Nat Rev Nephrol       Date:  2019-06       Impact factor: 28.314

Review 4.  Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM).

Authors:  Juan Jesús Carrero; Peter Stenvinkel; Lilian Cuppari; T Alp Ikizler; Kamyar Kalantar-Zadeh; George Kaysen; William E Mitch; S Russ Price; Christoph Wanner; Angela Y M Wang; Pieter ter Wee; Harold A Franch
Journal:  J Ren Nutr       Date:  2013-03       Impact factor: 3.655

5.  Comparative associations of muscle mass and muscle strength with mortality in dialysis patients.

Authors:  Naohito Isoyama; Abdul Rashid Qureshi; Carla Maria Avesani; Bengt Lindholm; Peter Bàràny; Olof Heimbürger; Tommy Cederholm; Peter Stenvinkel; Juan Jesús Carrero
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-29       Impact factor: 8.237

6.  Dynapenic obesity and the risk of incident Type 2 diabetes: the English Longitudinal Study of Ageing.

Authors:  D J Cuthbertson; J A Bell; S Y Ng; G J Kemp; M Kivimaki; M Hamer
Journal:  Diabet Med       Date:  2015-11-14       Impact factor: 4.359

Review 7.  Diabetes and end-stage renal disease; a review article on new concepts.

Authors:  Seyed Bahman Ghaderian; Fatemeh Hayati; Shokouh Shayanpour; Seyed Seifollah Beladi Mousavi
Journal:  J Renal Inj Prev       Date:  2015-06-01

8.  Association between sarcopenic obesity and higher risk of type 2 diabetes in adults: A systematic review and meta-analysis.

Authors:  Dima Khadra; Leila Itani; Hana Tannir; Dima Kreidieh; Dana El Masri; Marwan El Ghoch
Journal:  World J Diabetes       Date:  2019-05-15

Review 9.  Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity.

Authors:  S Goya Wannamethee; Janice L Atkins
Journal:  Proc Nutr Soc       Date:  2015-04-27       Impact factor: 6.297

Review 10.  Covid-19 and the impact on the physical activity level of elderly people: A systematic review.

Authors:  Murilo Rezende Oliveira; Isabella Pessóta Sudati; Vanessa De Mello Konzen; Ana Carolina de Campos; Lia Mara Wibelinger; Clisman Correa; Fabiano Moraes Miguel; Rebeca Nunes Silva; Audrey Borghi-Silva
Journal:  Exp Gerontol       Date:  2021-12-23       Impact factor: 4.032

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.